Last checked at (Sharecast News) - Fevertree: Barclays upgrades to buy with a target price of 2,500p.
Taylor Wimpey: Berenberg reiterates buy with a target price of 210p.
Centamin: Berenberg reiterates buy with a target price of 133p.
Litigation Capital Management: Canaccord reiterates buy with a target price of 94p.
Helium One Global: Canaccord initiates at speculative buy with a target price of 20p.
Ultra Electronics: JP Morgan reiterates overweight with a target price of 2,500p.
Croda: JP Morgan reiterates underweight with a target price of 5,550p.
AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,200p.
GSK: Deutsche Bank reiterates sell with a target price of 1,150p.
Reckitt Benckiser: Barclays reiterates overweight with a target price of 9,100p.
Cineworld: Peel Hunt downgrades to hold with a target price of 105p.
Knights: Liberum reiterates buy with a target price of 500p.
Ergomed: Numis downgrades to add with a target price of 1,330p.
Bunzl: RBC Capital Markets upgrades to sector perform with a target price of 2,270p.
7 Dec 2021 12:02
Liberum upgrades Rio Tinto to 'hold', says bad news priced in
(Sharecast News) - Liberum upgraded Rio Tinto to 'hold' from 'sell' on Tuesday as it argued that bad news was now priced in.
Read more